SEPIN BIOTECH

Sepin Biotech is currently developing Sepin-1 as a therapy for breast cancer in patients' human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.